Healthcare >> CEO Interviews >> November 3, 2017
Julian Aleksov is Co-Founder and Executive Chairman of Oasmia Pharmaceutical AB. Mr. Aleksov co-founded Oasmia Pharmaceutical AB in 1999 and has been its Executive Chairman since May 2015 and its Executive Director since 1999. He served as the Chief Executive Officer of Oasmia Pharmaceutical AB until May 28, 2015. Mr. Aleksov coordinates research projects, strategic development within bio-organic chemistry and strategic development of global intangible assets. He is a Co-Owner of Alceco International S.A. Profile
Anders Blom is Executive Vice President and Interim CFO of Oasmia Pharmaceutical AB. Employed since 2014, Mr. Blom has more than 15 years of experience from international strategic business development and finance at Q-Med and Pharmacia. He has a master’s degree in business administration from Uppsala University. His last employment was as CEO of Nexttobe AB, a Swedish venture capital company. Profile
TWST: Could you briefly describe Oasmia Pharmaceutical?
Mr. Aleksov: We are a company that launched 17 years ago in Uppsala, Sweden, which is outside of Stockholm. We focus on novel